Trial Profile
A multicentre randomised controlled trial of drug-eluting versus bare metal stents in the treatment of patients over 80 years of age with complex coronary artery disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms XIMA
- Sponsors Abbott Vascular
- 25 Oct 2014 United Kingdom Clinical Research Network reports accrual to date changed from 49% to 50%.
- 06 Nov 2013 Results published in the Journal of the American College of Cardiology.
- 11 Mar 2013 Primary endpoint results presented at the 62nd Annual Scientific Session of the American College of Cardiology.